WallStreetZenWallStreetZen

NASDAQ: ALPN
Alpine Immune Sciences Inc Stock Ownership - Who owns Alpine Immune Sciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Alpine Immune Sciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2644,000$11.31
$497.64kBuy
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2673,764$22.31
$1.65MSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2673,764$6.51
$480.20kBuy
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-2644,000$25.00
$1.10MSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-25236$22.00
$5.19kSell
James Paul RickeySenior Vice President Chief Financial Officer and Corporate Secretary2024-01-25236$6.51
$1.54kBuy
Xiangmin CuiDirector2024-01-181,234,636$12.74
$15.73MBuy
Decheng Capital China Life Sciences Usd Fund Iii LP10% Owner2024-01-181,234,636$12.74
$15.73MBuy
Peter A. ThompsonDirector2024-01-11145,251$12.74
$1.85MBuy
Orbimed Advisors LLCDirector2024-01-11145,251$12.74
$1.85MBuy

1 of 7

ALPN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALPN insiders and whales buy or sell their stock.

ALPN Shareholders

What type of owners hold Alpine Immune Sciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital China Life Sciences Usd Fund Iii LP12.12%7,942,924$512.87MInsider
Decheng Capital LLC10.81%7,083,288$457.37MInstitution
Jay Venkatesan10.48%6,871,153$443.67MInsider
Mitchell Gold8.24%5,398,672$348.59MInsider
Ra Capital Management LP7.49%4,909,763$317.02MInstitution
James N. Topper5.84%3,828,377$247.20MInsider
Lynx1 Capital Management LP5.82%3,813,926$246.27MInstitution
James E. Flynn5.69%3,732,412$241.00MInsider
Great Point Partners LLC5.65%3,703,433$239.13MInstitution
Paradigm Biocapital Advisors LP4.85%3,176,743$205.12MInstitution

1 of 3

ALPN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALPN59.43%40.57%Net Buying
NUVL70.71%29.29%Net SellingNet Selling
BBIO55.86%44.14%Net SellingNet Selling
CRSP62.44%37.56%Net BuyingNet Buying
KRYS75.55%24.45%Net SellingNet Selling
View Top Biotech Stocks

Alpine Immune Sciences Stock Ownership FAQ

Who owns Alpine Immune Sciences?

Alpine Immune Sciences (NASDAQ: ALPN) is owned by 89.91% institutional shareholders, 61.37% Alpine Immune Sciences insiders, and 0.00% retail investors. Decheng Capital China Life Sciences Usd Fund Iii LP is the largest individual Alpine Immune Sciences shareholder, owning 7.94M shares representing 12.12% of the company. Decheng Capital China Life Sciences Usd Fund Iii LP's Alpine Immune Sciences shares are currently valued at $513.27M.

If you're new to stock investing, here's how to buy Alpine Immune Sciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.